NCT05551559Enrolling by invitation
The Effect of Bariatric Surgery on Hepatic Metabolism in Non-Alcoholic Fatty Liver Disease
Source: ClinicalTrials.gov · Last updated 22 Sept 2022 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to investigate the mechanisms underlying bariatric surgery-induced resolution of non-alcoholic fatty liver disease.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- First submitted
- 14 Sept 2022
- Start date
- 12 Sept 2022
- Primary completion date
- Aug 2026
- Lead sponsor
- Helsinki University Central Hospital
- Diseases
- Fatty liver disease (MASLD/MASH)
- NCT number
- NCT05551559
What you commit to
- Study type: Interventional
- Planned participants: 180
- From 12 Sept 2022 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- No claustrophobia or metal implants to allow magnetic resonance spectroscopy.
Other
- No pregnancy or lactation in women.
Who the study is looking for
- Participants must have undergone bariatric surgery and previously participated in a metabolic study in our research group.
- Participants must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent.
- Age range from 18-75 years.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Biomedicum 2U Coordinator of this site? Confirm its status | Helsinki | Finland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.